Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Thielitz

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Molecular and Cellular Endocrinology|August 11, 2015
Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitroYasaman Mirdamadi, Anja Thielitz, Antje Wiede, et al.
The Journal of Investigative Dermatology|October 19, 2007
Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblastsAnja Thielitz, Robert W Vetter, Bianca Schultze, et al.
Biological Chemistry|January 4, 2011
PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J miceDirk Reinhold, Ute Bank, Dominik Entz, et al.
Clinical Chemistry and Laboratory Medicine|March 31, 2009
Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functionsSiegfried Ansorge, Ute Bank, Anke Heimburg, et al.
Advances in Experimental Medicine and Biology|May 17, 2006
Possible role of DP IV inhibitors in acne therapyAnja Thielitz, Dirk Reinhold, Robert Vetter, et al.
The Journal of Investigative Dermatology|June 17, 2006
Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiationAnja Thielitz, Dirk Reinhold, Robert Vetter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 16, 2026
S2k guideline occupational skin products: skin protection creams, skin cleansing and skin care productsMichal Gina, Manigé Fartasch, Andrea Bauer, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Molecular and Cellular Endocrinology|August 11, 2015
Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitroYasaman Mirdamadi, Anja Thielitz, Antje Wiede, et al.
The Journal of Investigative Dermatology|October 19, 2007
Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblastsAnja Thielitz, Robert W Vetter, Bianca Schultze, et al.
Biological Chemistry|January 4, 2011
PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J miceDirk Reinhold, Ute Bank, Dominik Entz, et al.
Clinical Chemistry and Laboratory Medicine|March 31, 2009
Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functionsSiegfried Ansorge, Ute Bank, Anke Heimburg, et al.
Advances in Experimental Medicine and Biology|May 17, 2006
Possible role of DP IV inhibitors in acne therapyAnja Thielitz, Dirk Reinhold, Robert Vetter, et al.
The Journal of Investigative Dermatology|June 17, 2006
Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiationAnja Thielitz, Dirk Reinhold, Robert Vetter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 16, 2026
S2k guideline occupational skin products: skin protection creams, skin cleansing and skin care productsMichal Gina, Manigé Fartasch, Andrea Bauer, et al.
Pageof 3